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Procalcitonin Is a Marker of Gram-Negative Bacteremia
in Patients With Sepsis
Shun Yuan Guo, MD, Yin Zhou, MD, Qing Feng Hu, PhD, Jiong Yao, PhD and Hong Wang, MD
Abstract: Background: Prediction of the species of pathogen among
patients with sepsis within hours would be helpful in accelerating
proper treatment. As a potential method of shortening the time to
identiﬁcation, this study considered the usefulness of measuring
procalcitonin (PCT) to predict blood culture (BC) results.
Methods: The authors retrospectively analyzed the data of patients
with a diagnosis of sepsis in their hospital from December 2012 to
December 2013. The authors analyzed all diagnostic episodes consist-
ing of BC and PCT concentration. The diagnostic performance of PCT
to predict gram-negative bacteremia was tested using a receiver
operative characteristic curve. Logistic regression was constructed
using the presence of gram-negative bacteria as the dependent variable.
Results: A total of 262 diagnostic episodes met the inclusion criteria.
According to BC classiﬁcations, a signiﬁcantly higher value of PCT was
observed in bloodstream infections caused by gram-negative bacteria
(26.7 ng/mL, 0.09–188.3) than that in bloodstream infections caused by
gram-positive bacteria (0.84 ng/mL, 0.05–18.79) or Candida spp.
(1.12 ng/mL, 0.07–49.68). A cutoff value of $3.39 ng/mL for PCT
showed a sensitivity of 80%, a speciﬁcity of 71%, a positive predictive
value of 35%, a negative predictive value of 91% and an area under the
curve of 0.73 for gram-negative bacteremia identiﬁcation by BC. Among
the 122 diagnostic episodes with positive BC results, a cutoff value of
$6.47 ng/mL for PCT yielded a sensitivity of 74%, a speciﬁcity of 81%,
a positive predictive value of 82%, a negative predictive value of 75% and
an area under the curve of 0.81 for gram-negative bacteremia identiﬁca-
tion. Conclusions: PCT may represent a useful tool for differentiating
gram-positive from gram-negative bloodstream infection with a signiﬁ-
cantly higher PCT level indicating gram-negative bacteremia.
Key Indexing Terms: Procalcitonin; Sepsis; Bacteremia; C-reactive
protein. [Am J Med Sci 2015;349(6):499–504.]
S epsis is among the most common causes of death in hos-pitalized patients. Despite improvements in antimicrobial
therapy, it is still associated with high mortality.1 In cases
where sepsis is suspected, timely and adequate clinical deci-
sion making is required. A delay in starting adequate antibi-
otic treatment is an independent predictor of high mortality.2,3
Empirical antimicrobial therapy should be started upon suspi-
cion of sepsis before blood culture results become available.
However, in one third of sepsis patients, the causative patho-
gens cannot be identiﬁed.4
Because of concerns regarding the potential for
a b-lactam–resistant gram-positive coccal infection, such as
methicillin-resistant Staphylococcus aureus infection, patients
with suspected severe sepsis require empiric combination anti-
microbial therapy with speciﬁc activity against gram-positive
cocci and agents with efﬁcacy against gram-negative bacte-
ria.5 This is especially true if the patient is known to have
acquired sepsis in the hospital. However, the need for combi-
nation antimicrobial therapy covering gram-positive cocci has
long been debated.6 Given the signiﬁcant negative impact of
the broad use of anti-positive cocci antimicrobials, such as the
emergence of vancomycin-resistant enterococci,7 better target-
ing of their use is needed. If the infectious pathogen could be
quickly identiﬁed by laboratory tests within an hour, it will
allow a more timely and accurate clinical decision and more
appropriate empirical antibiotic therapy.
Procalcitonin (PCT) is the prohormone of calcitonin and
is synthesized by the C cells in the thyroid gland. It is produced
ubiquitously in response to endotoxin or to mediators released
in response to bacterial infections.8 As such, it has become the
mostly widely used biomarker in the management of sepsis
around the world. PCT has the highest sensitivity and speciﬁc-
ity for predicting systemic bacterial inﬂammation; moreover,
high PCT concentrations have a positive predictive value for
severe sepsis and septic shock and distinguish between viral
and bacterial infections.9–11 The levels of PCT correlate with
the severity of bacterial infection and bacterial load. PCT may
assist in decisions about the initiation and/or duration of anti-
biotic therapy (antibiotic stewardship).12 Moreover, pieces of
studies have described the correlation between PCT concentra-
tion and identiﬁcation of speciﬁc bacterial species,13,14 but the
results needs to be validated. The aim of this study was to
investigate whether serum PCT level could be used as an early
surrogate marker for bacterial species-level detection by blood
culture (BC) in septic patients. In addition, the authors investi-
gated the predictive value of serum PCT level compared with
standard clinical inﬂammatory biomarkers such as white blood
cell (WBC) count, C-reactive protein (CRP) and platelet (PLT)
count and prediction rules.
METHODS
Patients and Definitions
This was a retrospective observational clinical study and
was approved by the Ethics Committee of Zhejiang Provincial
People’s Hospital. The written informed consent was given by
participant. The authors reviewed the clinical records of all pa-
tients with a diagnosis of sepsis or septic shock from December
2012 to December 2013 and registered those in agreement with
the diagnostic protocol consisting of a blood culture and mea-
surement of serum PCT. The authors excluded the diagnostic
episodes done on patients with missing tests and those not com-
pleted with an 8-hour time interval. Clinical and microbiologic
data were obtained from the comprehensive electronic medical
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record. For each complete diagnostic episode, the testing physi-
cians collected all patient information using a standardized data
collection form.
Demographic factors and comorbid illnesses, including
age, sex, diabetes mellitus, renal failure and malignancy were
evaluated. The 1st available physical examination ﬁndings were
collected; including altered mental status, pulse rate, respiratory
rate, blood pressure and body temperature. Laboratory tests
included PCT level, CRP level, WBC count, PLT count, blood
urea nitrogen, arterial pH, arterial lactic acid, oxygen saturation
with the fraction of inspired oxygen and Sequential Organ
Failure Assessment score. When inclusion criteria were met
more than once for a single patient during the intensive care unit
admission (ie, new bloodstream infection [BSI] documented by
blood culture), the authors considered this event a new
diagnostic episode for data analysis. In the hospital, a set of 2
blood specimens is drawn from each patient for BC, according
to the guidelines of the Infectious Diseases Society of America.
According to the results of each microbiological test, diagnostic
episodes were classiﬁed into 6 groups: gram-positive bacterial
infection, gram-negative bacterial infection, mixed infection-1
(gram-positive bacterial and gram-negative bacterial infection),
mixed infection-2 (bacterial infection and Candida spp. infec-
tion), Candida infection and negative.
Measurements
Serum PCT concentration was measured by chemilumines-
cent enzyme immunoassay using Modular E170 (Roche Diag-
nostics, Mannheim, Germany). Serum CRP concentrations were
measured by luminescent oxygen channeling immunoassay using
Immage 800 (Beckman Coulter, Brea, CA). WBC and PLT counts
FIGURE 1. Study flow chart. BC, blood culture; PCT, procalci-
tonin.
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were performed using the Cell-Dyn Sapphire (Abbott Diagnos-
tics Division, Santa Clara, CA). Blood culture was performed
using an automated system (BACTEC 9050; Becton-Dickinson,
San Jose, CA). Positive blood cultures were examined following
standard procedures. In cases where only 1 set of coagulase-
negative staphylococcus was detected, the authors considered it
to be contamination and judged the results as “negative.”
Statistical Analysis
Variables distribution was analyzed by D’Agostino-
Pearson’s test. For variables with normal distribution, the au-
thors calculate and reported mean and standard deviation. Vari-
ables without a normal distribution were expressed as median and
ranges. Categorical variables were compared using the x2 test.
The Kruskal–Wallis test was used to analyze the effect of a clas-
siﬁcation factor on ordinal data when the distribution of the
sample was not normal. The diagnostic performance of PCT
was evaluated using a receiver operating characteristic curve.
The cutoff value of PCT to predict gram-negative bacteremia
was selected considering the sum of the highest sensitivity and
speciﬁcity. Logistic regression analysis was performed to deter-
mine the independent factors associated with the presence of
gram-negative bacteremia. A value of P , 0.05 was considered
statistically signiﬁcant. Statistical analysis was performed using
SPSS for Windows (version 11.5; SPSS Inc, Chicago, IL).
RESULTS
Patient Characteristics
A total of 280 patients with sepsis were selected for the
analysis accounting for a total of 292 diagnostic episodes. Of
these, 262 met the inclusion criteria (Figure 1). One hundred
two episodes were from the intensive care unit, 137 were from
internal medicine, 45 from infectious disease, 16 from gastro-
enterology, 24 from respirology, 23 from neurology, 10 from
immunology, 12 from nephrology and 7 from oncohematology.
BC detected 108 BSI caused by bacteria (65 gram-
negative, 36 gram-positive, 7 mix-1, 11 Candida spp., 3
[mix-2] and 140 negative). Laboratory data and characteristics
of all diagnostic episodes are shown in Table 1. In infections
demonstrated by BC, a higher percentage was gram-negative
BSI. PCT values are shown in Table 2. Considering BC results,
a signiﬁcantly higher PCT value was observed in gram-negative
BSI (26.7 ng/mL, 0.09–188.3) than gram-positive BSI (0.84
ng/mL, 0.05–18.79) or in Candida spp. BSI (1.12 ng/mL,
0.07–49.68, P , 0.001) (Figure 2).
Independent Risk Factors Associated With
Gram-Negative Bacteremia Among Patients
With Sepsis
Univariate and multivariate logistic regression analyses
were performed for the principal study sample to examine PCT,
CRP, PLT and lactic acid levels and WBC count as potential
independent predictors of gram-negative BSI. As described in
Table 3, PCT and CRP were independent factors predicting
gram-negative BSI among all episodes. However, among the
subgroup with a positive BC result, PCT was the only predictor
of gram-negative BSI even after adjustments (Table 4).
Performance of Procalcitonin Values in Predicting
Gram-Negative Bloodstream Infection
Among all episodes, the area under the receiver operat-
ing characteristic curve (AUROC) of PCT to identify gram-
negative bacteremia was 0.73 (95% conﬁdence interval [CI],
0.66–0.81, P , 0.001). A cutoff value of 3.39 ng/mL for PCT
showed a sensitivity of 80%, a speciﬁcity of 71%, a positive
predictive value (PPV) of 35%, a negative predictive value
(NPV) of 91% and a diagnostic accuracy of 0.60. For compar-
ison, the AUROC of CRP to identify gram-negative bacteremia
was 0.46 (95% CI, 0.46–0.67, P 5 0.31) (Figure 3). However,
TABLE 2. C-reactive protein and procalcitonin levels in different cohorts according to blood culture results
Bacterial species CRP (mg/mL) P PCT (ng/mL) P
Acinetobacter (n 5 5) 198 (30–262) 0.2 16.6 (0.37–132) ,0.0001
Escherichia (n 5 13) 128 (11–128) 29.9 (1.14–180)
Klebsiella (n 5 21) 171 (15–278) 48.17 (0.9–188.3)
Enterobacter (n 5 20) 156.8 (20–230) 16.8 (0.1–94)
Pseudomonas (n 5 4) 198 (30–262) 16.6 (0.37–137)
Enterococcus (n 5 7) 63.3 (20–188) 0.26 (0.5–2.8)
Staphylococcus (n 5 24) 148.2 (37–288) 0.8 (0.77–8.8)
Streptococcus (n 5 2) 112.5 (13–212) 2.4 (0.3–4.5)
Candida (n 5 11) 135.4 (0.6–341) 2.9 (0.7–49.7)
Corynebacterium (n 5 3) 73.8 (1.4–128) 3.9 (0.6–18.7)
CRP, C-reactive protein; PCT, procalcitonin.
FIGURE 2. Box-plot distribution of procalcitonin values accord-
ing to blood culture classification.
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among the 122 diagnostic episodes with positive BC results,
a higher percentage of subsequent diagnostic episodes (53.3%)
was encountered in gram-negative BSI (P , 0.001). Median of
CRP and PCT in different cohorts and comparison of measured
values are included in Table 2. Signiﬁcantly, higher PCT levels
were founds in patients with Escherichia, Klebsiella and
Acinetobacter as determined by BC. Candida, Enterococcus
and Staphylococcus were linked with mild PCT elevation.
Moreover, among episodes with positive results of BC, the
AUROC of PCT to identify gram-negative bacteremia was
0.81 (95% CI, 0.74–0.89, P , 0.001) (Figure 4). A cutoff value
of 6.47 ng/mL for PCT showed a sensitivity of 74%, a speciﬁc-
ity of 81%, a PPV of 82%, a NPV of 75% and a diagnostic
accuracy of 0.79 (Table 3).
DISCUSSION
In this study, the authors assessed the relationship
between PCT levels and the blood culture results in patients
with sepsis. The results show that PCT and CRP levels
independently predicted gram-negative BSI among sepsis
episodes. However, PCT had a higher AUROC for predicting
gram-negative bacteremia than did CRP. Furthermore, the
authors identiﬁed a cutoff value for PCT with a high NPV
(0.91) to rule out the presence of gram-negative bacterial
species. The ﬁnding of a signiﬁcantly higher PCT level in
gram-negative BSI than in gram-positive BSI and fungal BSI
is consistent with previous reports.13,14 The high NPV of
PCT for detection of gram-negative bacteria through BC
may represent a useful tool to exclude the presence of
gram-negative BSI and guide the empirical antimicrobial
therapy regimens in critically ill patients; this has the advan-
tage of reducing costs and optimizing treatment. Thus, mea-
surement of PCT is a useful tool in differentiating Candida
spp. and gram-positive BSI from gram-negative BSI.
In this study, gram-negative BSI was more prevalent in
patients with positive BC results (gram-negative in 53% of cases
and gram-positive in 29.5% of cases). Fungal infection was
identiﬁed in only 5.7% of individuals. Staphylococci were iden-
tiﬁed as the most frequent causal pathogen, followed by Klebsi-
ella and Enterobacter; this is consistent with prior observations.
In general, staphylococci and gram-negative rods from the Enter-
obacteriaceae family are the most common causative agents of
sepsis.14,15 The highest PCT values were present in patients with
Escherichia coli, Klebsiella spp. and Pseudomonas spp. as deter-
mined using BC. In contrast, Candida spp., Streptococcus and
Enterococcus were associated with mildly elevated PCT regard-
less of disease severity. This may be explained by the recognition
of sepsis as a complex immune response to different pathogens.
In vitro studies have clearly described the difference of gram-
negative, gram-positive and fungal agents in the initiation of
inﬂammatory cascades,12,16 during which lipopolysaccharide pat-
terns of gram-negative bacteria may activate neutrophils through
the Toll-like receptor (TLR)-4, whereas lipoteichoic acid from
gram-positive bacteria act through TLR-2.16 TLR activation trig-
gers inﬂammatory cascades leading to synthesis of proinﬂamma-
tory cytokines and acute phase proteins.
Gram-negative infections probably increase tumor necro-
sis factor alpha production more than do gram-positive infec-
tions, and differences have also been found in plasma levels of
interleukin (IL)-1, IL-6, IL-10 and IL-8.16 That gram-negative
bacteremia induces a greater inﬂammatory response than gram-
positive bacteremia may help explain the higher PCT levels in
gram-negative bacteremia. In addition, in BSI due to gram-
negative and Candida spp., PCT was higher than that in BSI
caused only by fungal or negative BSI but was lower than that
in gram-negative bacteremia. This ﬁnding may be explained by
the recognition of sepsis as a complex immune response to patho-
gens with an early hyperinﬂammatory response followed by an
impaired immunity and anti-inﬂammatory phase. Due to this
susceptibility, a secondary nosocomial infection such as Candida
spp. infection may occur.17 Thus, measuring PCT levels in the
case of a mixed infection is important because a growing number
of critically ill patients in immunoparalysis are prone to fungal
infection and prompt administration of antifungal therapy is piv-
otal to reduce mortality.9
TABLE 3. Univariate and multivariate regression analysis of gram-negative BSI in all episodes
Variable Crude OR, n (range) P Adjusted OR, n (range) P
Age 1.0 (0.99–1.02) 0.32 1.0 (0.98–1.03) 0.62
Male sex 0.72 (0.38–1.35) 0.3 0.66 (0.31–1.39) 0.27
WBC 1.03 (0.99–1.06) 0.13 1.04 (0.99–1.08) 0.1
PLT 0.99 (0.99–1.00) 0.18 1.0 (0.99–1.0) 0.68
CRP 0.99 (0.99–1.0) 0.23 0.99 (0.99–1.0) 0.04
PCT 1.02 (1.01–1.03) ,0.001 1.02 (1.01–1.03) ,0.001
Lactic acid 1.11 (0.99–1.24) 0.07 1.03 (0.91–1.16) 0.62
CRP, C-reactive protein; OR, odds ratio; PCT, procalcitonin; PLT, platelet count; WBC, white blood cell count.
TABLE 4. Univariate and multivariate regression analysis of PCT for gram-negative bloodstream infection in episodes with
positive blood culture results
Predictor (ng/mL) Unadjusted OR (95% CI) P Adjusted OR (95% CI) P
PCT (0–3) 0.10 (0.05–0.24) ,0.001 0.11 (0.05–0.27) ,0.001
PCT (3–6) 0.35 (0.09–1.41) 0.12 0.29 (0.07–1.24) 0.09
PCT ($6) 10.9 (4.65–26.63) ,0.001 10.3 (10.3–24.7) ,0.001
CI, conﬁdence interval; OR, odds ratio; PCT, procalcitonin.
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BC reﬂects the current gold standard for detection of
BSI. The practical value of BC in diagnosis of sepsis, however,
is limited by the delayed results and because positive blood
cultures are found in only approximately 30% of patients.18,19
This study shows that PCT concentration, along with CRP, was
a potential independent predictive factor of gram-negative BSI
as identiﬁed using BC among all patients with sepsis. The
AUROC for PCT was 0.73, which was signiﬁcantly higher than
that for CRP (0.46, P 5 0.001). Sensitivity of 80% and
speciﬁcity of 71% were achieved with a PCT cutoff value of
3.39 ng/mL. Similar conclusions have been reported by Charles
et al.20 Moreover, according to the patients with positive BC
results, the AUROC of PCT in diagnosis of gram-negative
bacteremia was 0.81. A cutoff value of 6.47 ng/mL for PCT
showed a sensitivity of 74%, a speciﬁcity of 81% and a PPV of
82%. For comparison, CRP levels did not signiﬁcantly differ
among patients with gram-negative bacterial septicemia, gram-
positive bacteremia and fungal BSI. Hence, PCT levels could
serve as a simple utility for conﬁrmation or exclusion of gram-
negative BSI in patients with sepsis. A signiﬁcantly higher PCT
level was a marker of gram-negative bacteremia. Thus, the
authors could improve the diagnostic effect combine PCT with
other markers such as WBC, CRP and IL-6.
Some limitations of this study need to be considered.
First, this study is a retrospective design and had a low number
of infections with Candida spp., reﬂecting the low prevalence
of fungal BSI. Second, the patient populations in this study are
selected, and the gram-negative bacteremia was twice as prev-
alent as in this study as gram-positive bacteremia, which may
indicate some selection bias. It may originate from the charac-
teristic epidemiology of pathogens causing BSI in the authors’
general ICU with a high admission rate of surgical patients.
This setting leads to the high prevalence of gram-negative
pathogens in this population as responsible for BSI. However,
previous studies found that gram-negative bacteria is the major
pathogen in sepsis.19 Another limitation is that the diagnostic
performance of PCT was investigated only in conjunction with
BC results and did not use other identiﬁcation methods, such as
real-time polymerase chain reaction (PCR), which may have
increased the number of positive results.21 However, the PCR
technique as diagnostic tool for septicemia may preclude poten-
tial contamination with clinically insigniﬁcant pathogenic
DNA.22 Moreover, PCR-based molecular techniques require
technical skills and equipment that may not readily be available.
In conclusion, a higher PCT level was found in patients
with a gram-negative BSI than in those with gram-positive
BSI. Thus, PCT may represent a useful tool for differentiating
gram-positive from gram-negative BSI with a signiﬁcantly
higher PCT level indicating gram-negative bacteremia.
Measurement of serum PCT may be adopted as a component
of a diagnostic strategy to guide empirical antimicrobial
therapy regimens in sepsis patients.
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